Plus Therapeutics and Genomic Testing Cooperative Partner to Integrate Next-Generation Sequencing Into the CNSide® CSF Assay Platform

Go back to Plus Therapeutics and Genomic Testing Cooperative Partner to Integrate Next-Generation Sequencing Into the CNSide® CSF Assay Platform
(NASDAQ: PSTV) Delayed: 3.87 --0 (-0%)
Previous Close $3.87    52 Week High
Open $3.87    52 Week Low
Day High $3.87    P/E N/A 
Day Low $3.87    EPS
Volume 12,892